QuantRx Biomedical Corporation (QTXB)
USD 0.0
(400.0%)
USD 0.0
(400.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 156.00 USD | -93.58% |
| 2014 | 2430.00 USD | -60.25% |
| 2013 | 6113.00 USD | -59.88% |
| 2012 | 15.23 Thousand USD | -20.17% |
| 2011 | 19.08 Thousand USD | -98.72% |
| 2010 | 1.49 Million USD | -41.45% |
| 2009 | 2.55 Million USD | 308.53% |
| 2008 | 624.49 Thousand USD | -16.41% |
| 2007 | 747.11 Thousand USD | 716.85% |
| 2006 | 91.46 Thousand USD | 64.37% |
| 2005 | 55.64 Thousand USD | -16.15% |
| 2004 | 66.36 Thousand USD | 49.37% |
| 2003 | 44.42 Thousand USD | 0.0% |
| 2002 | - USD | -100.0% |
| 2001 | 10 Thousand USD | -66.67% |
| 2000 | 30 Thousand USD | -57.14% |
| 1999 | 70 Thousand USD | -83.33% |
| 1998 | 420 Thousand USD | 366.67% |
| 1997 | 90 Thousand USD | -52.63% |
| 1996 | 190 Thousand USD | 280.0% |
| 1995 | 50 Thousand USD | 0.0% |
| 1994 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 FY | - USD | -100.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 Q2 | 626.00 USD | 301.28% |
| 2015 FY | 156.00 USD | -93.58% |
| 2015 Q4 | - USD | -100.0% |
| 2015 Q1 | 156.00 USD | -74.47% |
| 2015 Q3 | 590.00 USD | -5.75% |
| 2014 Q3 | 590.00 USD | -5.75% |
| 2014 Q4 | 611.00 USD | 3.56% |
| 2014 Q1 | 602.00 USD | -39.5% |
| 2014 Q2 | 626.00 USD | 3.99% |
| 2014 FY | 2430.00 USD | -60.25% |
| 2013 Q2 | 965.00 USD | -71.12% |
| 2013 Q3 | 812.00 USD | -15.85% |
| 2013 Q4 | 995.00 USD | 22.54% |
| 2013 Q1 | 3341.00 USD | 40.85% |
| 2013 FY | 6113.00 USD | -59.88% |
| 2012 Q4 | 2372.00 USD | -60.76% |
| 2012 Q2 | 2304.00 USD | -48.97% |
| 2012 Q3 | 6045.00 USD | 162.37% |
| 2012 Q1 | 4515.00 USD | 5.42% |
| 2012 FY | 15.23 Thousand USD | -20.17% |
| 2011 Q4 | 4283.00 USD | 6.7% |
| 2011 FY | 19.08 Thousand USD | -98.72% |
| 2011 Q3 | 4014.00 USD | 112.61% |
| 2011 Q2 | 1888.00 USD | -78.79% |
| 2011 Q1 | 8900.00 USD | 166.63% |
| 2010 FY | 1.49 Million USD | -41.45% |
| 2010 Q3 | 190 Thousand USD | -70.36% |
| 2010 Q1 | 659.29 Thousand USD | -46.4% |
| 2010 Q2 | 641.04 Thousand USD | -2.77% |
| 2010 Q4 | 3338.00 USD | -98.24% |
| 2009 Q3 | 989.29 Thousand USD | 473.79% |
| 2009 Q2 | 172.41 Thousand USD | 8.11% |
| 2009 Q4 | 1.23 Million USD | 24.34% |
| 2009 Q1 | 159.48 Thousand USD | 3.09% |
| 2009 FY | 2.55 Million USD | 308.53% |
| 2008 Q2 | 161.08 Thousand USD | 74.77% |
| 2008 Q1 | 92.17 Thousand USD | -81.23% |
| 2008 FY | 624.49 Thousand USD | -16.41% |
| 2008 Q4 | 154.7 Thousand USD | -28.55% |
| 2008 Q3 | 216.52 Thousand USD | 34.41% |
| 2007 Q3 | 85.51 Thousand USD | -21.02% |
| 2007 FY | 747.11 Thousand USD | 716.85% |
| 2007 Q2 | 108.28 Thousand USD | 73.61% |
| 2007 Q4 | 490.95 Thousand USD | 474.09% |
| 2007 Q1 | 62.36 Thousand USD | 85.21% |
| 2006 Q4 | 33.67 Thousand USD | 4.89% |
| 2006 Q2 | 12.84 Thousand USD | 0.0% |
| 2006 Q1 | 12.84 Thousand USD | -25.0% |
| 2006 FY | 91.46 Thousand USD | 64.37% |
| 2006 Q3 | 32.1 Thousand USD | 150.03% |
| 2005 Q3 | 12.84 Thousand USD | 0.0% |
| 2005 Q1 | 12.84 Thousand USD | 0.0% |
| 2005 Q4 | 17.12 Thousand USD | 33.34% |
| 2005 FY | 55.64 Thousand USD | -16.15% |
| 2005 Q2 | 12.84 Thousand USD | 0.0% |
| 2004 Q1 | 27.84 Thousand USD | 0.0% |
| 2004 Q2 | 17.12 Thousand USD | -38.5% |
| 2004 Q3 | 8561.00 USD | -50.0% |
| 2004 Q4 | 12.84 Thousand USD | 49.99% |
| 2004 FY | 66.36 Thousand USD | 49.37% |
| 2003 FY | 44.42 Thousand USD | 0.0% |
| 2002 FY | - USD | -100.0% |
| 2002 Q1 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | 10 Thousand USD | -66.67% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q1 | - USD | -100.0% |
| 2000 Q4 | 10 Thousand USD | 0.0% |
| 2000 FY | 30 Thousand USD | -57.14% |
| 2000 Q1 | 10 Thousand USD | 0.0% |
| 2000 Q2 | 10 Thousand USD | 0.0% |
| 2000 Q3 | 10 Thousand USD | 0.0% |
| 1999 Q4 | 10 Thousand USD | 0.0% |
| 1999 Q3 | 10 Thousand USD | -50.0% |
| 1999 Q1 | 30 Thousand USD | -40.0% |
| 1999 FY | 70 Thousand USD | -83.33% |
| 1999 Q2 | 20 Thousand USD | -33.33% |
| 1998 Q2 | 170 Thousand USD | 70.0% |
| 1998 Q1 | 100 Thousand USD | 66.67% |
| 1998 Q3 | 100 Thousand USD | -41.18% |
| 1998 Q4 | 50 Thousand USD | -50.0% |
| 1998 FY | 420 Thousand USD | 366.67% |
| 1997 Q4 | 60 Thousand USD | 500.0% |
| 1997 FY | 90 Thousand USD | -52.63% |
| 1997 Q3 | 10 Thousand USD | -50.0% |
| 1997 Q2 | 20 Thousand USD | 100.0% |
| 1997 Q1 | 10 Thousand USD | 0.0% |
| 1996 Q2 | 10 Thousand USD | -93.33% |
| 1996 FY | 190 Thousand USD | 280.0% |
| 1996 Q4 | - USD | -100.0% |
| 1996 Q3 | 30 Thousand USD | 200.0% |
| 1996 Q1 | 150 Thousand USD | 1400.0% |
| 1995 Q3 | - USD | -100.0% |
| 1995 Q4 | 10 Thousand USD | 0.0% |
| 1995 Q2 | 50 Thousand USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 FY | 50 Thousand USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | 100.0% |
| Ansell Limited | 1.61 Billion USD | 100.0% |
| Ansell Limited | 1.61 Billion USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 184.64 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | 135.05 Thousand USD | 100.0% |
| Psykey, Inc. | 419.29 Thousand USD | 100.0% |
| ConvaTec Group Plc | 2.19 Billion USD | 100.0% |
| ConvaTec Group Plc | 2.14 Billion USD | 100.0% |
| Encision Inc. | 6.58 Million USD | 100.0% |
| Golden Valley Development, Inc | - USD | NaN% |
| Hear AtLast Holdings, Inc. | - USD | NaN% |
| Innovative MedTech Inc. | 1.82 Million USD | 100.0% |
| LifePoint, Inc. | -18.5 Thousand USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | 100.0% |
| Remedent, Inc. | 986.22 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | 1.08 Million USD | 100.0% |
| SmileDirectClub, Inc. | 470.74 Million USD | 100.0% |
| Sector 10, Inc. | - USD | NaN% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 100.0% |
| SheerVision, Inc. | 3.49 Million USD | 100.0% |
| United Health Products, Inc. | - USD | NaN% |
| Vasamed, Inc. | 1.38 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | 100.0% |
| Yubo International Biotech Limited | 104.28 Thousand USD | 100.0% |